Bilal Arshad Khan

CIK: 0002108044

Transaction Breakdown

Open Market Buys (P)2 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SGP

SpyGlass Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Purchase(P)
Direct
20K shares at avg. $16.00$320K
SGP
SpyGlass Pharma, Inc.
Feb 9, 2026
Purchase(P)
Indirect
115K shares at avg. $16.00$1.8M
SGP
SpyGlass Pharma, Inc.
Feb 5, 2026
Award(A)
Stock Option (right to buy)
Direct
13.7K shares-

		Type	Shares	Price		Ownership
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Purchase(P)	20,000	$16.00	$320,000	Direct
Feb 9, 2026	SGP SpyGlass Pharma, Inc.	Purchase(P)	115,000	$16.00	$1,840,000	Indirect
Feb 5, 2026	SGP SpyGlass Pharma, Inc.	Award(A) Stock Option (right to buy)	13,700	-	-	Direct

1-3 of 3 transactions

About Khan Bilal Arshad

Khan Bilal Arshad (SEC CIK 0002108044) files insider reports with the SEC as Director of SpyGlass Pharma, Inc. (SGP).

Signal8 holds 3 ownership filings by Khan Bilal Arshad (1 Form 3, 2 Form 4), filed between Feb 5, 2026 and Feb 11, 2026. Those filings report 3 transactions, from Feb 5, 2026 to Feb 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Khan Bilal Arshad's filings is in ALISO VIEJO, CA.

Recent filings by Khan Bilal Arshad

Feb 9, 2026: Open-market purchases of SGP shares (2 lines, Form 4, code P).
Feb 5, 2026: Grant or award of SGP derivative securities (Form 4, code A).

Other insiders filing for SpyGlass Pharma, Inc. (SGP)

RA CAPITAL MANAGEMENT, L.P., Director
Nielsen Kirk G., Director
Behbahani Ali, Director
Florence Anthony A. Jr., 10% Owner
BASKETT FOREST, 10% Owner
New Enterprise Associates 17, L.P., 10% Owner

How to read Form 4 transaction codes